Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
CA Stock MarketDetailed Quotes
Quantum BioPharma Ltd (QNTM)
- 7.580
- -0.220-2.82%
15min DelayMarket Closed May 1 15:58 ET
44.19MMarket Cap-0.67P/E (TTM)
8.200High7.380Low15.11KVolume7.800Open7.800Prev Close118.37KTurnover52.00052wk High0.28%Turnover Ratio5.83MShares2.85052wk Low-11.254EPS TTM40.65MFloat Cap52.000Historical HighLossP/E (Static)5.36MShs Float2.850Historical Low-11.254EPS LYR10.51%Range %--Dividend TTM4.66P/B1Lot Size--Div Yield TTM
Quantum BioPharma Ltd (QNTM) Cash Flow
Quarterly+Annual
YOY
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -19.79%-8.24M | 63.43%-305.6K | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M |
| Net income from continuing operations | -80.73%-26.96M | 32.13%-3.7M | -18.24%-4.75M | -191.31%-9.77M | -317.89%-8.74M | 18.18%-14.92M | -230.37%-5.46M | -254.96%-4.02M | 38.94%-3.35M | 79.00%-2.09M |
| Operating gains losses | 518.85%10.6M | 104.33%126.39K | 300.78%522.71K | 5,204.64%8.74M | 150.17%1.21M | 54.29%-2.53M | 46.18%-2.92M | -3,341.25%-260.34K | 150.18%164.68K | 133.89%484.04K |
| Depreciation and amortization | 11.25%545.78K | 14.69%129.37K | 20.30%145.34K | 3.34%141.38K | 7.95%129.69K | -80.43%490.57K | -7.70%112.8K | -17.71%120.81K | -87.65%136.81K | -89.37%120.14K |
| Asset impairment expenditure | --0 | ---- | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Unrealized gains and losses of investment securities | 253.27%513.91K | 929.86%1.5M | ---782.88K | ---920.2K | --718.83K | -61.56%145.47K | 40.87%145.47K | --0 | --0 | --0 |
| Remuneration paid in stock | 1,835.11%2.95M | 1,080.22%808.45K | 1,422.67%996.19K | 661.79%849.58K | 404.43%291.27K | -96.03%152.21K | -182.99%-82.48K | -48.14%65.42K | -72.35%111.52K | -98.20%57.74K |
| Other non cashItems | 8,826.60%2.13M | 2,626.36%182.88K | 30.22%13.51K | 1,015.68%93.24K | 14,755.00%1.84M | -1.59%23.9K | -100.15%-7.24K | 100.52%10.37K | 100.29%8.36K | 423.14%12.41K |
| Change In working capital | -79.65%1.99M | -91.15%652.18K | 244.75%2.13M | -146.57%-1.08M | 151.09%284.21K | 495.72%9.76M | 926.00%7.37M | -46.04%618.21K | 1,126.30%2.32M | -245,168.28%-556.31K |
| -Change in receivables | -62.64%1.69M | -75.10%817.03K | 156.36%295.69K | -94.67%61.35K | -15.90%513.61K | 719.87%4.52M | 6,701.00%3.28M | -220.15%-524.65K | 232.14%1.15M | 349.13%610.74K |
| -Change in inventory | 155.53%65.11K | 121.74%25.49K | ---753 | --16.99K | --23.39K | ---117.24K | ---117.24K | --0 | --0 | --0 |
| -Change in prepaid assets | -37.78%53.75K | -70.47%24K | 2,179.95%413.93K | -316.50%-308.88K | 36.01%-75.31K | -72.73%86.38K | -57.87%81.29K | -112.90%-19.9K | -57.39%142.67K | 67.79%-117.68K |
| -Change in payables and accrued expense | -72.40%1.18M | -106.86%-214.34K | 22.33%1.42M | -85.66%147.92K | 83.09%-177.48K | 108.33%4.27M | 443.46%3.13M | 109.60%1.16M | 233.69%1.03M | -271.81%-1.05M |
| -Change in other working capital | -200.00%-1M | --0 | --0 | ---- | ---- | --1M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | 0 | |||||||||
| Operating cash flow | -19.79%-8.24M | 63.43%-305.6K | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -29.86%-1.95M | -71.81%350.65K | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -457.74%-1.5M | 1.24M | -1,184.78%-3.46M | 738.22K | -22.14K |
| Net PPE purchase and sale | ---- | ---- | ---- | --85.72K | --268.29K | --0 | ---- | ---- | --0 | --0 |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net business purchase and sale | --0 | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | -29.86%-1.95M | -71.81%350.65K | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -398.92%-1.5M | --1.24M | -1,049.28%-3.46M | --738.22K | ---22.14K |
| Cash from discontinued investing activities | 0 | |||||||||
| Investing cash flow | -29.86%-1.95M | -71.81%350.65K | 111.79%408.42K | -284.41%-1.36M | -5,998.50%-1.35M | -457.74%-1.5M | --1.24M | -1,184.78%-3.46M | --738.22K | ---22.14K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -47.51%6.1M | -42.68%1.41M | -96.12%261.43K | -30.09%1.29M | 450.97%3.13M | 471.61%11.62M | 9,885.24%2.47M | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K |
| Net issuance payments of debt | 452.88%5.24M | -103.93%-38.62K | 186.18%264.92K | 147,699.16%1.93M | 1,033.97%3.09M | 601.58%948.25K | 3,989.26%982.08K | -461.21%-307.41K | 102.39%1.31K | 601.31%272.28K |
| Net common stock issuance | -96.83%338.33K | -77.25%337.89K | --0 | -99.98%439 | --0 | 460.76%10.67M | 4,368,917.65%1.49M | --7.05M | --1.84M | 110.02%296.44K |
| Proceeds from stock option exercised by employees | --191.34K | --0 | --0 | --145.46K | --45.89K | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | --326.6K | --1.12M | ---3.5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -47.51%6.1M | -42.68%1.41M | -96.12%261.43K | -30.09%1.29M | 450.97%3.13M | 471.61%11.62M | 9,885.24%2.47M | 12,400.66%6.74M | 4,378.90%1.84M | 118.94%568.72K |
| Net cash flow | ||||||||||
| Beginning cash position | 117.47%6M | -85.71%445.94K | -54.71%1.5M | 164.49%3.52M | 117.47%6M | -83.76%2.76M | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M | -83.76%2.76M |
| Current changes in cash | -226.30%-4.09M | -49.25%1.46M | -464.13%-1.05M | -202.24%-2.02M | -73.64%-2.48M | 122.77%3.24M | 427.94%2.88M | 90.85%-186.42K | 155.64%1.98M | 81.61%-1.43M |
| End cash Position | -68.22%1.91M | -68.22%1.91M | -85.71%445.94K | -54.71%1.5M | 164.49%3.52M | 117.47%6M | 117.47%6M | -14.14%3.12M | -41.69%3.31M | -85.58%1.33M |
| Free cash from | -19.79%-8.24M | 63.43%-305.6K | 50.26%-1.72M | -221.38%-1.95M | -115.91%-4.26M | 36.49%-6.88M | 1.87%-835.76K | -102.08%-3.46M | 82.72%-606.48K | 58.49%-1.97M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm